GBX Technologies adds TOPFX as Liquidity provider

Hong Kong (PRWEB) July 07, 2014

GBX Technologies Ltd, the Hong Kong-based developer of bespoke foreign exchange technology solutions, is pleased to announce the expansion of its liquidity providers to include TopFx, the global Prime Broker. Authorised and regulated by the Cyprus Securities and Exchange Commission with a cross-border license to provide services to all European Union member states, TopFX sources foreign exchange liquidity from eleven top-tier banks and delivers tight spreads and substantial depth-of-market to end users.

"We are pleased to incorporate TopFX as a liquidity provider. Their commitment to providing tight liquidity and excellent pricing to clients and traders is consistent with GBX's commitment to being the premier technology provider in the forex bridging industry. We look forward to expanding our relationship with TopFX to provide additional value-add to our respective clients," reports Eric Lowe, Managing Director of GBX Technologies Ltd (Asia).

TopFX adheres to a 100% agency model and maintains a 'no-compete' policy, meaning there are no conflicts of interest with its clients. This model includes no set-up fee, no minimum volumes, no hidden costs, and no minimum deposits. TopFX's prospective clients can evaluate its services without any commitments including instant execution with a very low level of trade rejection. Additionally, TopFX is pleased to provide customized liquidity solutions based on its customers' requirements.

"When you partner high quality FX liquidity with high quality bridging software like GBX, the basis for first-class business is in place," says Gabriel Styllas, CEO of TopFX.

About GBX Technologies Ltd
GBX Technologies Ltd is the Hong Kong-based developer of advanced foreign exchange technology solutions, combining bespoke hardware solutions with proprietary software applications encompassing bridging solutions, risk management, liquidity distribution, charting and analytics, and prime brokerage technology solutions. mrs & rsv

Read the full story at http://www.prweb.com/releases/2014/07/prweb12000056.htm